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Abstract
In vitro follicular culture systems provide optimal culture models for research about the
physiology of the ovary and support the clinical practices to achieve competent mature
oocytes for in vitro fertilization. In vitro maturation of preantral follicles makes it possible to
study the effects of therapeutic agents on various conditions or disorders of the ovary.
Nowadays, preventive bioflavonoids against cancer, hypercholesterolemia, fatty liver, or a
variety of toxic agents are in focus. The aim of this study was to design and investigate the
impacts of different concentrations of hesperidin, a glycoside flavonoid, on the in vitro
preantral follicle growth and maturation in the three-dimensional (3D) culture system
which was made with sodium alginate. Preantral follicles (n¼ 1363) were mechanically
isolated from immature mice ovaries, then, after capsulating, they were randomly divided
into four groups: the control group received no concentration of hesperidin, and three
experimental groups were supplemented with 10, 22.5, and 50 mmol/L of hesperidin. All
groups were cultured for 12 days. At the end of the culture period, the percentage of
survival rate, antrum formation, obtained metaphase II oocytes, and the secretion of 17b-
estradiol and progesterone were significantly higher in the group Hesp 50 (50 mmol/L hesperidin). Moreover, the mean average of
follicular diameter cultured in the group Hesp 50 was also increased and the mRNA expression levels of PCNA, FSH-R, and Bcl-2
genes were higher, while Bax mRNA expression was significantly reduced compared with the other groups. Follicles cultured in
the presence of 50 mmol/L of hesperidin had a higher fertilization rate and embryo development. Adding hesperidin at the con-
centration of 50 mmol/L to the culture medium resulted in higher follicular growth and maturation and increased the rate of in vitro
fertilization and embryo development.
Keywords: Ovarian follicle culture, hesperidin, hormones, gene expression, in vitro maturation, in vitro fertilization
Experimental Biology and Medicine 2019; 244: 352–361. DOI: 10.1177/1535370219831615
Impact statement
It has been stated that hesperidin has
many pharmacological effects, such as
anti-inflammatory and antioxidant effects,
antimicrobial activity, and anti-
carcinogenic activity; but hesperidin and its
derivatives have been under investigation
as anti-fertility factors for a very long time.
However, our results show that hesperidin
can improve mice follicular growth and
maturation during in vitro 3D culture.
Hesperidin as an antioxidant factor could
enhance the mRNA expression levels of
two important genes involved in folliculo-
genesis, PCNA, and FSH-R. Our results
prove for the first time that hesperidin not
only has deleterious effects on follicular
development but can also increase rates of
in vitro fertilization and embryo
development.
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Introduction
Within the ovaries of rodents or humans, folliculogenesis,
as a major issue in fertility, occurs as a complex and dynam-
ic process, in which an interaction between the somatic cells
of supporting cells (i.e. theca and granulosa cells (GCs))
and the oocyte leads to ovulation.1–4 Numerous factors
affect ovulation and fertility, and it is a challenge to deal
with infertility and infertility-causing diseases, such as
polycystic ovary syndrome.5–7
In vitromaturation (IVM) of immature or preantral ovar-
ian follicles can be used as an accepted model in order to
perceive the mechanisms that may occur during folliculo-
genesis and also in order to study or find out the effects of
multiple factors such as endocrines, antioxidants, nutrients,
vitamins, and locally acting factors on follicular develop-
ment.3 On the other hand, in vitro follicular culture
systems, two-dimensional (2D) and three-dimensional
(3D), not only provide optimal culture models for ovarian
physiology research but also support the clinical practice to
achieve competent mature oocytes for in vitro fertilization
(IVF).3,8 Preantral follicle isolations from the ovary can
be carried out by two common methods (mechanical and
enzymatic) for culturing.3,4 In the 2D culture system,
both forms of isolated follicles lose their integrity by the
migration and attachments of GCs around the oocyte and
to the culture dishes, respectively.3,4 Therefore, 2D systems
cannot provide an excellent correlation with the in vivo
conditions.3,8 However, isolated follicles can not only main-
tain their integrity in 3D cultures but also provide an encap-
sulated space around the follicles using hydrophobic
membranes that prevent follicular attachment to the culture
dishes. Hence, a good correlation with the in vivo condi-
tions can be achieved in 3D systems.3,8
Numerous studies have been conducted to investigate
fertility and infertility mechanisms and affecting factors,
but these issues remain challenging.3,9 Additionally, the
effects of diverse factors added to the culture media of
the follicles can be investigated during IVM of prean-
tral follicles.3
Nowadays, the search to assess the preventive effects
of therapeutic agents, as potential health benefits, against
various disorders is the target of excessive research;
especially, preventive bioflavonoids against cancer, hyper-
cholesterolemia, fatty liver, or a variety of toxic agents are
in focus.10–20
Hesperidin (Hesp) (Figure 1) (5, 7, 30-trihydroxy-40-
methoxy-flavanone7-rhamnoglucoside) is a bioflavonoid,
which is abundant in citrus fruits, such as orange and
lemon, and plant-derived beverages, such as tea and olive
oil commonly used in traditional medicines.21 It has been
reported that Hesp has diverse pharmacological actions,
such as antioxidant, anticarcinogenic, analgesic, antiviral,
antibacterial, antifungal, antiulcer, anti-inflammatory, and
anticancer activity (Figure 1).21 The anti-proliferative effect
of Hesp against MCF-7 cells and its apoptotic effect on
colon and pancreatic cancer cells have been reported.22–24
Interestingly, hesperidin was found to be safe during preg-
nancy; no side effects had been recorded even after the oral
administration of the compounds in combination with
diosmin to treat hemorrhoids.21 Recent epidemiological
data reinforced the safety of hesperidin in pregnancy.25
Furthermore, one study reported the neuroprotective activ-
ity of Hesp in a murine model of aluminum-induced neu-
rotoxicity.26 Toxicological studies have recently reported
that Hesp can protect many tissues against toxic agents-
induced oxidative injuries by its antioxidant and
free radical-scavenging activity.21,27 It has been found that
Hesp, by its strong cellular antioxidant protection, could
decrease the damaging effects induced by cyclophospha-
mide (CP) treatment.28 Hesp can also facilitate the forma-
tion of vitamin C complex; hence, it can support the healthy
immune system functions.29 Hesperidin, as a flavanone gly-
coside, comprises an aglycone,Hesperetin. It has been found
that Hesperetin can inhibit the oxidative stress via estrogen
receptor-mediated actions and, as an antioxidant, it can
improve the quality of porcine oocytes during aging
in vitro.30
However, based on our current knowledge, the efficien-
cy of hesperidin on ovarian follicles in a long-term culture
Figure 1. The chemical structure and biological activities of hesperidin. Hesperidin possesses a wide range of bioactivities useful for clinical applications, such anti-
inflammatory, antimicrobial, antioxidant, and anticancer activities.
Shoorei et al. Hesperidin and follicular development 353
...............................................................................................................................................................
has not been described before. Therefore, the aim of this
study was to investigate the effects of different concentra-
tions of hesperidin on the follicular development of isolated
preantral follicles in the 3D culture system made with
sodium alginate hydrogel.
Material and methods
Animals, follicle isolation, and experimental design
Fifty NMRI (National Medical Research Institute)
female mice (12–14 week old) were used with the permis-
sion of the Animal Research Ethical Committee of the
Tabriz University of Medical Sciences (IR.TBZMED.
REC.1396.555). Mice were terminated by cervical disloca-
tion, and bilateral ovaries were dissected and placed imme-
diately in a-minimal essential medium (a-MEM) (Gibco,
UK), which was supplemented with 10% fetal bovine
serum (FBS) (Gibco, UK). The preantral follicles were iso-
lated mechanically under a laboratory stereomicroscope,
then the intact follicles were chosen for 3D culture which
had two or three layers of GCs with normal (i.e. round) and
centrally located oocytes with the size of 125–135 mm.3
The preantral follicles (n¼ 1363) were divided into four
groups. The control group (n¼ 286) was not treated with
any additional supplementations, while groups Hesp 10
(n¼ 357), Hesp 22.5 (n¼ 369), and Hesp 50 (n¼ 351) were
supplemented with 10, 22.5, and 50 mmol/L of hesperidin,
respectively.31 The culture medium for all of the study
groups was a-MEM medium, which was supplemented
with 1% insulin-transferrin-selenium (ITS) (Gibco, UK),
100 mIU/mL of recombinant follicle-stimulating hormone
(rFSH) (Serono, Switzerland), 100 IU/mL of penicillin,
50 lg/mL of streptomycin, and 5% FBS.3,4
3D in vitro culture of isolated follicles
For encapsulating isolated follicles, we used sodium
alginate as has been previously described.3,4 In brief, 1 g
of sodium alginate powder was dissolved in 10mL of
deionized water. Then, 0.5 g of charcoal was added to the
solution to remove hydrogel impurities. The solution was
centrifuged at 5000 r/min for 1 min, and then the removed
transparent solution was stored at 4C. Before each encap-
sulation, to prepare sodium alginate solution at a concen-
tration of 0.5% (w/v), it was diluted with sterile phosphate
buffer saline (PBS). Then, droplets of sodium alginate
(8mL) were put into the sterile culture dishes, and each
isolated follicle was transferred inside each droplet of
sodium alginate by using a micropipette. At the end of
the process, they were immersed in the cross-linking solu-
tion containing CaCl2 (50 mM) and NaCl (140 mM) for 1 to
2 min. Then, after removing alginate beads from the cross-
linking solution, they were washed with a-MEMmedia and
transferred to a droplet (50 mL) of culture media in Petri
dishes (SPL, Life Science, Korea), which was filled with 20
droplets of culture media. The encapsulated follicles were
cultured under mineral oil (Sigma, Germany) for 12 days in
an incubator (37C, 5% CO2). Moreover, every other day,
half of the media was changed.3,4
Assessment of follicular morphology
On days 0, 6, and 12 of the cell culture periods, the mor-
phology of follicles was checked using an inverted micro-
scope (Olympus, Japan), and the photo of the follicles was
taken at 10 magnification. Then, follicle size was mea-
sured by ImageJ software (n¼ 40 for each group). On the
last day (day 12) of the cell culture, 1.5 IU/mL of human
chorionic gonadotropin (HCG) (Organon, The
Netherlands) was added to the culture medium of all
groups to induce oocyte maturation and ovulation. The
released oocytes were considered as germinal vesicle
(GV), germinal vesicle breakdown (GVBD), as well as meta-
phase II (MII), which had been described in our previ-
ous study.3,4
Hormonal assays
On the last day of the cell culture, half of the medium of
each follicle culture medium from all subgroups (n¼ 5 for
each subgroup, at least three times) was collected to inves-
tigate the levels of steroid hormones, 17-b estradiol (E2),
and progesterone (P4). E2 and P4 were measured with a
radioimmunoassay kit (Orion Diagnostica, Finland,
sensitivity¼ 6.5 pg/mL) and an enzyme-linked immuno-
sorbent assay kit (DiaPlus, USA, sensitivity¼ 0.1 ng/mL),
respectively.3,4
RNA extraction, cDNA synthesis, and real-time
RT-qPCR
The total cellular RNA from follicles (n¼ 12, last day of
culture) was extracted using TRIzol reagent (Invitrogen,
Karlsruhe, Germany) and was carried out according to
the manufacturer’s protocol. The synthesis of cDNA was
done according to the manufacturer’s instructions
(Fermentas Inc., Hanover, MD, USA). The mRNA expres-
sion levels of Bax, Bcl-2, FSH-R, and PCNA genes were
analyzed by GAPDH as a housekeeping gene. For PCR
reactions, primers were adapted from other primers
(as designed on the NCBI website or in our previous
studies)3,32 and synthesized by Cinnagen (Table 1). PCRs
were performed using Master Mix and SYBR Green I in an
Applied Biosystems, StepOneTM thermal cycler (Applied
Biosystems, USA). The program started with an initial
melting cycle for 5 min at 95C to activate the polymerase,
followed by 40 cycles of melting (30 s at 95C), annealing
(30 s at 58C) and expanse (30 s at 72C). The quality of the
PCR reactions was confirmed by melting curve analyses.
For each sample, the reference gene (GAPDH) and target
genes were amplified in the same run. Reference genes
were almost equal. The target genes were normalized to a
reference gene and calculated with the Pfaffl method
(2DDCt, DDCt¼DCtSample–DCtControl).33
IVF and embryo culture
For performing IVF, in the first stage, the cauda epididymis
of male NMRI mice (eight-week old, n¼ 10) was dissected
and placed immediately into human tubal fluid (HTF)
medium (Sigma Aldrich, Germany), which had been sup-
plemented with 5 mg/mL of bovine serum albumin (BSA)
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(Gibco, UK), for 1.5 h for sperm capacitation. In the second
stage, after capacitation, the collected MII oocytes were
transferred from all subgroups of the study to HTF
medium, which contained capacitated spermatozoa and
was supplemented with 15mg/mL of BSA for a period of
6 h. In the third stage, after insemination, the oocytes were
transferred to the global medium, which was supple-
mented with 5mg/mL of BSA and were cultured for five
days (120 h). During this period, the IVF and developmen-
tal rates for 2-cell embryos, morula, and hatching blastocyst
embryos were assessed daily.34
Statistical analysis
Statistical analysis was carried out with SPSS software ver-
sion 22 (SPSS, SPSS Inc., USA). Data were assessed for nor-
mality with the Kolmogorov–Smirnov test. All results are
presented as mean SD and assessed with one-way
ANOVA Tukey’s post hoc tests. p< 0.05 was considered
as significant.
Results
The inverted microscope images and the mean
diameter of cultured follicles
The inverted microscope images and the mean diameter of
cultured isolated preantral follicles in all the groups are
shown in Figures 2 and 3.
At the initiation of the cell culture (day 0), the mean
diameter of encapsulated follicles was around 131 lm.
On day 6, the diameters of follicles increased in all cultured
groups (200 5.9, 204 5.69, 209 6.11, and 2.16
 5.19 mm), and a significant increase was found in
groups Hesp 22.5 and Hesp 50 as compared with the con-
trol group (p< 0.05). In this part, the largest diameter was
observed in group Hesp 50 (p< 0.05). Furthermore, at the
end of the culture period—day 12—the mean diameter of
follicles in groups Hesp 22.5 and Hesp 50 was significantly
increased (316 9.27 and 327 11.03 mm, respectively)
as compared with the control and Hesp 10 groups
(295 11.2 and 299 11.9 mm, respectively) (p< 0.05).
However, the largest diameter was observed in the follicles
of group Hesp 50 (p< 0.05).
There was no significant difference between the control
group and experimental 1 group on days 6 and 12 of culture.
Follicular developmental rate
Developmental rates of encapsulated cultured follicles in
all cultured groups are summarized in Table 2. The rates
of surviving follicles, antrum formation, and MII oocytes
were significantly increased in groups Hesp 22.5 and Hesp
50 in comparison with two other groups of the culture
(p< 0.05). Among all groups, the highest rate was observed
in group Hesp 50 (p< 0.05). There was no significant dif-
ference between the control and Hesp 10 (10 mmol/L)
groups in these parameters.
Hormonal assays
Table 3 shows the concentrations of E2 as well as P4. As
shown in Table 3, in groups Hesp 22.5 and Hesp 50, there
was a significant increase in hormone levels compared with
the control group and group Hesp 10 (p< 0.05). Moreover,
a significant difference was observed in the level of E2
when group Hesp 10 was compared with the control
group (p< 0.05). The highest hormonal productions were
observed in group Hesp 50 as compared with other groups
of the study.
Gene expression in follicles
The impacts of hesperidin on the expression levels of Bax,
Bcl-2, PCNA, as well as FSH-R mRNAwere investigated by
RT-qPCR. Figure 4 shows the relative expression levels,
which were normalized against the level of endogenous
GAPDH as an internal control. As shown in Figure 4,
although the expression of FSH-R as well as PCNA genes
was significantly higher in experimental groups 2
and 3 than in other groups (p< 0.05), the highest mRNA
expression of FSH-R and PCNA genes was observed in
experimental group 3 supplemented with 50 mmol/L
hesperidin. On the other hand, the mRNA expression of
the pro-apoptotic gene, Bax, was significantly decreased
in groups Hesp 22.5 and Hesp 50 when compared with
the control and Hesp 10 groups (p< 0.05), while the
lowest Bax mRNA expression was observed in group
Hesp 50 (p< 0.05). The relative expression of the Bcl-2
gene in experimental groups 2 and 3 was significantly dif-
ferent from that of the control and Hesp 10 groups
(p< 0.05). However, the highest mRNA expression of
Bcl-2, as one of the anti-apoptotic genes, was observed in
group Hesp 50 (p< 0.05).
Table 1. The characteristic of primer sequences used in real-time quantitative reverse transcription polymerase chain reaction assays.
Genes
Accession
numbers Primer sequence (50–30)
PCR product
size (bp)
Bax NM_017059.2 F: 50-TTTGCTACAGGGTTTCATCCAG-30
R: 50-GTCCAGTTCATCGCCAATTC-30
139
Bcl-2 NM_000633.2 F: 50-GAGAGCGTCAACAGGGAGAT-30
R: 50-ACAGCCAGGAGAAATCAAACA-30
169
FSH-R XM_011532735.2 F: 50-AGGTACAGCTCTGCCATGCT-30
R: 50-GTACGAGGAGGGCCATAACA-30
171
PCNA NM_011045.2 F: 50-GGAAGCTTAGAGTAGCTCTCATC-30
R: 50-GGGAATTCGTGACAGAAAAGACCTC-30
174
GAPDH NM-007393 F: 50-GGAAAAGAGCCTAGGGCAT-30
R: 50-CTGCCTGACGGCCAGG-30
64
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Fertilization rate and embryo development
The fertilization rates of MII oocytes and embryo
development are summarized in Table 4. In addition, the
development of embryos is shown in Figure 5. As shown in
Table 4, the percentage of fertilization rate increased in all
experimental groups, while the highest percentage of fer-
tilization rate was found in group Hesp 50 (p< 0.05).
Moreover, embryo development—2-cell, morula, and
hatched—was higher in all groups receiving hesperidin
compared with the control group, but the highest
percentage of embryo development was observed in
group Hesp 50 (p< 0.05).
Discussion
It has been reported that preantral follicles can be success-
fully cultured and matured in 2D or 3D culture systems.3
IVC and IVM of immature ovarian follicles have been con-
sidered as a model to study the mechanisms of folliculo-
genesis at the genetic level.3 These methods are an
Figure 2. Images of the inverted microscope during in vitro three-dimensional follicular development in the alginate droplet on day 0 (first column), day 6 (second
column), and day 12 (third column) in different groups.
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alternative for breast cancer patients who are unable to
undergo ovarian stimulation and for the investigation of
the actions of hormones, toxicants, drugs, antioxidants on
oocyte, or somatic cells.3
For a very long time, hesperidin has been under investi-
gation as an antifertility factor.21 In 1948, it was reported
that phosphorylated hesperidin (PH) acts as an antifertility
agent by inhibiting the sperm enzyme hyaluronidase.35
Another study reported that the intraperitoneal adminis-
tration of PH (20 mg/kg) to both male and female mice
for eight days reduced the percentage of pregnancies
on mating.36
However, the present study was the first to demonstrate
that the addition of hesperidin positively affected the in
vitro 3D culture of preantral follicles isolated from the ova-
ries of immature mice (Figure 6). Our results showed that
the diameter of cultured follicles increased in all study
groups during 12 days of culture, and this effect of the
compound was dose dependent. On the other hand,
adding hesperidin to the culture media could enhance
follicular development rate, fertilization rate, and embryo
development in a dose-dependent manner.
During in vitro culture and maturation of preantral fol-
licles, they are maintained under higher concentrations of
O2; therefore, continuously in aerobic cells, free radicals are
produced and result in decreasing follicular development.3
However, ROS may affect follicular growth and matura-
tion.3 On the other hand, it may be a major cause of poor
oocyte quality and may thereby decrease the developmen-
tal competence of oocytes in vivo and in vitro.37 The bal-
ance between ROS and antioxidants influences follicular
growth and maturation because antioxidant supplements,
by reducing reactive oxygen species and inhibiting lipid
peroxidation, can lead to preventing cell damage, enhance
follicular development, and increase the fertilization rate
and embryo development.30 One study reported that
hesperidin, through its antioxidant action, provides the pro-
tection of fertility against oxidative stress induced by CP in
ovaries of rats.38 Another study showed that treatment with
Hesperetin could enhance the in vitro development of
aging porcine oocytes and the mRNA expression of some
cytoplasmic maturation marker genes, such as bone mor-
phogenetic protein 15 (BMP15) and growth differentiation
factor-9 (GDF9).30
Our results also showed that the gene expression of
PCNA, which can be found in fetal and adult ovaries of
several mammals, was significantly increased by hesperidin.
It has been reported that PCNA is a 36 kDa protein, which
increases during the initiation of follicle growth and acts as
Figure 3. The mean average of follicular diameter (lm) on days 0, 6, and 12 of
the experiment. a, b, and c show significant differences compared with the control
group, Hesp 10, and Hesp 22.5, respectively. On day 6, the administration of
hesperidin at the dose of 22.5 mmol/L caused greater increase in follicular
diameter in comparison with the control group (ap< 0.05); however, in the Hesp
50 group, the mean diameter of follicles was significantly increased compared
with the control, Hesp 10, and Hesp 22.5 (ap< 0.05, bp< 0.05, and cp< 0.001,
respectively). On day 12, the administration of hesperidin at the dose of 22.5
mmol/L could increase the follicular diameter in comparison with the control and
Hesp 10 groups (ap< 0.05 and bp< 0.05, respectively), while treatment with 50
mmol/L hesperidin (Hesp 50) caused greater increase in follicular diameter in
comparison with the control, Hesp 10, and Hesp 22.5 (ap< 0.05, bp< 0.05, and
cp<0.001, respectively). (A color version of this figure is available in the
online journal.)










Cont. 286 192 (67.13 2.31) 83 (43.22 3.09) 19 (22.89 1.19)
Hesp 10 357 249 (69.74 2.88) 114 (45.78 2.43) 29 (25.43 1.08)
Hesp 22.5 369 271 (73.44 2.71)a,b 133 (49.07 2.56)a,b 41 (30.82 1.11)a,b
Hesp 50 351 275 (78.34 2.01)a,b,c 149 (54.18 2.92)a,b,c 56 (37.58 1.15)a,b,c
Note: The control (Cont.) group contained 5% fetal bovine serum (FBS) without hesperidin, Hesp 10 was treated with 10 mmol/L hesperidin, Hesp 22.5 was treated
with 22.5 mmol/L hesperidin, and Hesp 50 was treated with 50 mmol/L hesperidin. Values are given as meanSD.
ap<0.05 as compared with the control group.
bp< 0.05 as compared with Hesp10 group.
cp<0.002 as compared with Hesp 22.5 group.
Table 3. The levels of steroid hormones, 17-b estradiol (E2), and pro-








Cont. 1872.81 62.35 16.93 2.21
Hesp 10 1987.74 58.12a 19.34 1.11
Hesp 22.5 2189.93 81.38a,b 27.69 2.02a,b
Hesp 50 2785.94 45.98a,b,c 35.67 1.08a,b,c
Note: The control (Cont.) group contained 5% fetal bovine serum (FBS) without
hesperidin, Hesp 10 was treated with 10 mmol/L hesperidin, Hesp 22.5 was
treated with 22.5 mmol/L hesperidin, and Hesp 50 was treated with 50 mmol/L
hesperidin. Values are given as meanSD.
ap< 0.05 as compared with the control group.
bp< 0.05 as compared with Hesp10 group.
cp< 0.001 as compared with Hesp 22.5 group.
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one of the key factors in cellular vital processes including
DNA replication and repair as well as cell survival during
the development of ovarian follicles. Hence, the hesperidin-
induced increase in PCNA gene expression can be partially
responsible for the proliferations of GCs.
On the other hand, our results showed that treatment
with hesperidin increases the expression of FSH-R mRNA
and the levels of E2 and P4 in the media. FSH-R is exclu-
sively located on GCs, and is essential for the ovarian
function and fertility. FSH-R is a glycoprotein that belongs
to the family of G protein-coupled receptors and is
expressed in growing follicles.31 On the other hand, FSH
plays an important role in ovarian follicular maturation,
oogenesis, and the production of steroid hormones;
hence, it is crucial for fertility39; in other words, when
the FSH binds its cognate receptor, it induces the follicular
transition from preantral to antral follicles and promotes
cytochrome P450.3 FSH can also increase the transcription
of CYP19A1 in GCs involved in converting theca cell-
derived androgens, namely dehydroepiandrosterone,
androstenedione, androstenediol, and testosterone into
estrogens, estradiol, and estrone.40,41 It has been indicated
that estrogens stimulate the proliferation of GCs and are
absolutely necessary for the normal follicle growth.40 We
have also found that hesperidin increased E2 and P4 levels in
follicular culture media dose dependently. The high level of
Figure 4. The mRNA expression levels of PCNA, FSH-R, Bcl-2, and Bax genes in all groups of the study–control, Hesp 10, Hesp 22.5, and Hesp 50—on the last day of
the culture period, day 12. Values are mean standard deviation (SD). Hesp: Hesperidin. (a) The mRNA expression of PCNA; a, b, and c show significant differences
compared with the control group (p<0.05), Hesp 10 group (p< 0.04), and Hesp 50 group (p< 0.003), respectively. (b) The mRNA expression of FSH-R; a, b, and c show
significant differences compared with the control group (p< 0.05), Hesp 10 group (p< 0.05), and Hesp 50 group (p< 0.001), respectively. (c) The mRNA expression of
Bcl-2; a, b, and c show significant differences compared with the control group (p< 0.05), Hesp 10 group (p< 0.05), and Hesp 50 group (p< 0.02), respectively. (d) The
mRNA expression of Bax; a, b, and c show significant differences compared with the control group (p< 0.05), Hesp 10 group (p< 0.003), and Hesp 50 group (p< 0.001),
respectively. (A color version of this figure is available in the online journal.)












Cont. 19 13 (68.42 0.3) 8 (61.53 0.6) 4 (30.76 0.4) 3 (23.07 0.8)
Hesp 10 27 19 (70.37 0.5) 12 (63.15 0.6) 6 (31.57 0.7) 5 (26.31 1.1)
Hesp 22.5 38 27 (71.05 0.5)a 18 (66.66 0.9)a 9 (33.33 1.2)a 8 (29.62 1.1)a
Hesp 50 51 39 (76.47 0.9)a,b,c 29 (74.35 1.4)a,b,c 16 (41.02 0.9)a,b,c 13 (33.33 1.2)a,b,c
Note: The control (Cont.) group contained 5% fetal bovine serum (FBS) without hesperidin, Hesp 10 was treated with 10 mmol/L hesperidin, Hesp 22.5 was treated
with 22.5 mmol/L hesperidin, and Hesp 50 was treated with 50 mmol/L hesperidin. Values are given as meanSD.
ap< 0.05 as compared with the control group.
bp< 0.05 as compared with Hesp10 group.
cp< 0.001 as compared with Hesp 22.5 group.
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P4 is related to increased activity of theca cells and to
enhanced aromatase activity in GCs.3,40 Therefore, it
seems that the hesperidin-induced increase in FSH-R gene
expression can be partially responsible for the elevated
estrogen hormones. Interestingly, one study found a poten-
tial impact of hesperidin against formaldehyde (FA,
2mg/kg) toxicity in pregnant rats; the results also
showed that the level of E2 (17b-estradiol) was significantly
higher in mice that orally received 50 mg/kg hesperidin and
in Hespþ FA groups than in the control and FA groups,
while the level of progesterone (P4) did not show a signif-
icant difference.42 Hence, we hypothesize that hesperidin
might upregulate FSH-R gene expression to enhance follic-
ular development.
It has been interestingly proved that the accumulation of
ROS influences apoptosis.16,43 Flavonoids as antioxidants
Figure 6. In vitro 3D culture of isolated preantral follicles (from the ovaries of immature mice) by adding hesperidin. (A color version of this figure is available in the
online journal.)
Figure 5. Effect of hesperidin on embryo development. (a) a healthy MII oocyte. (b, c, and d) Embryo development in the stages of 2-cell, morula, and hatched,
respectively. (A color version of this figure is available in the online journal.)
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can neutralize reactive oxygen metabolites, and therefore
protect apoptosis-induced cell death.44 We have found that
hesperidin treatment led to an increase and a decrease in the
mRNA levels of Bcl-2 gene (anti-apoptotic) and Bax gene
(pro-apoptotic), respectively. Hesperidin was also found to
inhibit the generation of ROS.45 One study reported that
treatment with Hesperetin decreased the level of ROS in
aging porcine oocytes in vitro and significantly increased
the expression of antioxidant genes, such as peroxiredoxin
5, nuclear factor erythroid 2-like 2, and superoxide dismut-
ase 1 and 2.30 Thus, the improvement in follicular develop-
ment by hesperidin can partially be explained by its anti-
apoptotic activity.
Conclusion
According to these results, our study provides a mechanis-
tic link between the enhancement of follicular development
and the functions of E2, P4, PCNA, FSH-R, Bcl-2, and Bax.
The dose-dependent increase in the diameter of cultured
follicles, the increase of E2 and P4 levels in follicular culture
media, the increase of PCNA and FSH-R expression, the
increase of mRNA of Bcl-2 gene and the decrease in
mRNA of Bax gene levels might help follicular develop-
ment, offering a novel approach to developing a new
class of follicle developing and follicle enhancing agents.
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